PARP1 and breast cancer: Nevertheless, NA (a chemical inhibitor of PARP1) treatment increased the viral genome copy number in BC-3 cells, whereas HU (a PARP1 activator) treatment decreased it, suggesting that PARP1 may play a role in maintaining KSHV latency.